Literature DB >> 16235464

Intravenous anesthetics in sepsis.

Cheng-Ming Tsao1, Chin-Chen Wu, Jhi-Joung Wang, Chih-Shung Wong, Shen-Kou Tsai, Shung-Tai Ho.   

Abstract

Overactive inflammatory responses that destroy rather than protect are the crucial issues in the development of a spectrum of septic disease states, such as adult respiratory distress syndrome, systemic inflammatory response syndrome, septic shock, and multiple organ failure. This review focuses on an area in which alternative actions of intravenous anesthetics show much promise for sepsis: their effects on the inflammatory response and on inflammatory cells in vitro and in vivo. The endotoxin-induced pro-inflammatory cytokine activity and its consequent nitric oxide generation, free radicals production and neutrophil activity are generally depressed by intravenous anesthetics. Different intravenous anesthetics, such as propofol, ketamine, benzodiazepine and barbiturates, which produce different levels of inhibition of inflammatory effects, are discussed in this article. In addition, such modulations of inflammatory responses may be of great relevance to the practice of intensive care, and intravenous anesthetics may play significant roles in this regard.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16235464

Source DB:  PubMed          Journal:  Acta Anaesthesiol Taiwan


  5 in total

1.  Ketamine reduces intestinal injury and inflammatory cell infiltration after ischemia/reperfusion in rats.

Authors:  Francisco Javier Guzmán-De La Garza; Carlos Rodrigo Cámara-Lemarroy; Raquel Guadalupe Ballesteros-Elizondo; Gabriela Alarcón-Galván; Paula Cordero-Pérez; Nancy Esthela Fernández-Garza
Journal:  Surg Today       Date:  2010-11-03       Impact factor: 2.549

Review 2.  Anesthetic modulation of immune reactions mediated by nitric oxide.

Authors:  Noboru Toda; Hiroshi Toda; Yoshio Hatano
Journal:  J Anesth       Date:  2008-05-25       Impact factor: 2.078

3.  Ketamine anesthesia reduces intestinal ischemia/reperfusion injury in rats.

Authors:  Carlos Rodrigo Cámara; Francisco Javier Guzmán; Ernesto Alexis Barrera; Andrés Jesús Cabello; Armando Garcia; Nancy Esthela Fernández; Eloy Caballero; Jesus Ancer
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

4.  Renal Outcomes in Critically Ill Patients Receiving Propofol or Midazolam.

Authors:  Tacyano Tavares Leite; Etienne Macedo; Izanio da Silva Martins; Fernanda Macedo de Oliveira Neves; Alexandre Braga Libório
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-04       Impact factor: 8.237

5.  Effects of propofol on pro-inflammatory cytokines and nuclear factor kappaB during polymicrobial sepsis in rats.

Authors:  Xue-Min Song; Yan-Lin Wang; Jian-Guo Li; Cheng-Yao Wang; Qing Zhou; Zong-Ze Zhang; Hui Liang
Journal:  Mol Biol Rep       Date:  2009-02-04       Impact factor: 2.316

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.